A股午評：創業板指升0.29% 超2500股上升 黃金、港口航運股領升
A股主要指數早盤集體上升，截至午盤，滬指升0.09%報3429.36點，深成指升0.3%，創業板指升0.29%。全市場半日成交額9877億元，較上日縮量856億元，超2500只個股上升。
盤面上，現貨黃金突破3010美元創新高，黃金股走高，萊紳通靈、明牌珠寶升停；港口航運板塊盤中拉昇，招商港口、廈門港務、珠海港升停；藥明康德績後升超9%，帶動CRO概念上升，東方海洋升停。白酒、食品、養殖業板塊跌幅靠前，巖石股份跌超5%，蓋世食品跌超3%。比亞迪盤初一度升超2%報390元，創歷史新高，昨日發佈超級e平台，推出閃充電池、3萬轉電機和全新一代車規級碳化硅功率芯片。
現貨黃金突破3010美元創新高 黃金股走高
萊紳通靈、明牌珠寶升停，鵬欣資源、赤峯黃金升超7%，玉龍股份、盛達資源、中金黃金、山東黃金等跟升。
消息面上，現貨黃金突破3010美元/盎司，續創歷史新高。分析人士指出，金價創新高，原因是投資者權衡了加劇經濟放緩擔憂的美國數據，而中東緊張局勢的升級則進一步凸顯了黃金的避風港吸引力。
港口航運板塊盤中拉昇 招商港口、廈門港務、珠海港升停
招商港口、廈門港務、珠海港升停，國航遠洋升超13%，盛航股份、中遠海特、鹽田港等跟升。
消息面上，3月17日晚間，廈門港務正式披露了一項重大資產重組預案。根據預案內容，廈門港務計劃通過發行股份及支付現金的方式，向國際港務購買其持有的集裝箱碼頭集團70%的股權，並擬向不超過35名符合條件的特定對象發行股份以募集配套資金。
藥明康德績後升超9% 帶動CRO概念上升
東方海洋升停，藥明康德升超9%，聖諾生物升超6%，昭衍新藥、凱萊英、美迪西、康龍化成等跟升。
消息面上，藥明康德昨晚公佈的業績顯示，第四季度收入增至115.4億元，強勢突破22年第四季度創下的單季度營收峯值。TIDES業務板塊2024年營收同比增長70.1%至58億元，大幅超越此前所給出的全年60%的增速指引。另外，藥明康德公吿，公司擬以10億元資金回購股份。
白酒、食品、養殖業板塊跌幅靠前 巖石股份跌超5%
巖石股份跌超5%，康比特跌超4%，蓋世食品跌超3%，古井貢酒、立高食品、有友食品均跌超2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
